Mimedx (MDXG) Change in Account Payables (2012 - 2026)
Mimedx recorded quarterly Change in Account Payables of $1.9 million in Q1 2026, up 222.07% quarter-over-quarter from -$1.6 million in Q4 2025, and up 32.6% year-over-year from $1.5 million in Q1 2025.
Mimedx's Change in Account Payables history runs 15 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 32.6% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $2.6 million (up 1213.73% YoY), while the FY2025 annual figure was $2.1 million, up 250.28% from the prior year.
- Change in Account Payables came in at $1.9 million for Q1 2026 at Mimedx, up from -$1.6 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.9 million in Q3 2025 to a low of -$1.6 million in Q4 2025.
- A 5-year average of $251000.0 and a median of $283000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 6878.57% in 2023 and sank 330.68% in 2024, its largest moves.
- Mimedx's Change in Account Payables stood at -$251000.0 in 2022, then soared by 126.69% to $67000.0 in 2023, then surged by 964.18% to $713000.0 in 2024, then sank by 322.44% to -$1.6 million in 2025, then jumped by 222.07% to $1.9 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $1.9 million, -$1.6 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | -1.59 Mn |
| Dec 31, 2025 | -1.59 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Jun 30, 2025 | -668,000.00 |
| Jun 30, 2025 | -668,000.00 |
| Mar 31, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 713,000.00 |
| Dec 31, 2024 | 713,000.00 |
| Sep 30, 2024 | -1.05 Mn |
| Sep 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Mar 31, 2024 | 283,000.00 |
| Mar 31, 2024 | 283,000.00 |
| Dec 31, 2023 | 67,000.00 |
| Dec 31, 2023 | 67,000.00 |
| Sep 30, 2023 | 453,000.00 |
| Sep 30, 2023 | 453,000.00 |
| Jun 30, 2023 | 949,000.00 |
| Jun 30, 2023 | 949,000.00 |
| Mar 31, 2023 | -686,000.00 |
| Mar 31, 2023 | -686,000.00 |
| Dec 31, 2022 | -251,000.00 |
| Dec 31, 2022 | -251,000.00 |
| Sep 30, 2022 | 648,000.00 |
| Sep 30, 2022 | 648,000.00 |
| Jun 30, 2022 | -14,000.00 |
| Jun 30, 2022 | -14,000.00 |
| Mar 31, 2022 | 456,000.00 |
| Mar 31, 2022 | 456,000.00 |
| Dec 31, 2021 | 669,000.00 |
| Dec 31, 2021 | 669,000.00 |
| Sep 30, 2021 | -3.62 Mn |
| Sep 30, 2021 | -3.62 Mn |
| Jun 30, 2021 | 3.73 Mn |
| Jun 30, 2021 | 3.73 Mn |
| Mar 31, 2021 | -936,000.00 |
| Mar 31, 2021 | -936,000.00 |
| Dec 31, 2020 | -162,000.00 |
| Dec 31, 2020 | -162,000.00 |
| Sep 30, 2020 | -2.90 Mn |
| Sep 30, 2020 | -2.90 Mn |
| Jun 30, 2020 | 2.19 Mn |
| Jun 30, 2020 | 2.19 Mn |
| Mar 31, 2020 | 1.05 Mn |
| Mar 31, 2020 | 1.05 Mn |
| Dec 31, 2019 | -727,000.00 |
| Dec 31, 2019 | -727,000.00 |
| Sep 30, 2019 | -1.37 Mn |
| Sep 30, 2019 | -1.37 Mn |
| Jun 30, 2019 | 101,000.00 |
| Jun 30, 2019 | 101,000.00 |
| Mar 31, 2019 | -4.17 Mn |
| Mar 31, 2019 | -4.17 Mn |
| Dec 31, 2018 | 3.07 Mn |
| Dec 31, 2018 | 3.07 Mn |
| Sep 30, 2018 | -1.00 Mn |
| Sep 30, 2018 | -1.00 Mn |
| Jun 30, 2018 | -557,000.00 |
| Jun 30, 2018 | -557,000.00 |
| Mar 31, 2018 | 5.08 Mn |
| Mar 31, 2018 | 5.08 Mn |
| Dec 31, 2017 | -1.80 Mn |
| Dec 31, 2017 | -1.80 Mn |
| Sep 30, 2017 | 244,000.00 |
| Sep 30, 2017 | 244,000.00 |
| Jun 30, 2017 | 613,000.00 |
| Jun 30, 2017 | 613,000.00 |
| Mar 31, 2017 | -379,000.00 |
| Mar 31, 2017 | -379,000.00 |
| Dec 31, 2016 | 463,000.00 |
| Dec 31, 2016 | 463,000.00 |
| Sep 30, 2016 | 1.66 Mn |
| Sep 30, 2016 | 1.66 Mn |
| Jun 30, 2016 | -1.33 Mn |
| Jun 30, 2016 | -1.33 Mn |
| Mar 31, 2016 | -4.27 Mn |
| Mar 31, 2016 | -4.27 Mn |
| Dec 31, 2015 | -611,000.00 |
| Dec 31, 2015 | -611,000.00 |
| Sep 30, 2015 | 1.69 Mn |
| Sep 30, 2015 | 1.69 Mn |
| Jun 30, 2015 | 271,000.00 |
| Jun 30, 2015 | 271,000.00 |
| Mar 31, 2015 | 1.79 Mn |
| Mar 31, 2015 | 1.79 Mn |
| Dec 31, 2014 | 932,000.00 |
| Dec 31, 2014 | 932,000.00 |
| Sep 30, 2014 | 400,000.00 |
| Sep 30, 2014 | 400,000.00 |
| Jun 30, 2014 | -173,000.00 |
| Jun 30, 2014 | -173,000.00 |
| Mar 31, 2014 | 128,000.00 |
| Mar 31, 2014 | 128,000.00 |
| Dec 31, 2013 | 254,906.00 |
| Dec 31, 2013 | 254,906.00 |
| Sep 30, 2013 | 368,067.00 |
| Sep 30, 2013 | 368,067.00 |
| Jun 30, 2013 | 781,004.00 |
| Jun 30, 2013 | 781,004.00 |
| Mar 31, 2013 | -194,977.00 |
| Mar 31, 2013 | -194,977.00 |
| Dec 31, 2012 | -41,861.00 |
| Dec 31, 2012 | -41,861.00 |
| Sep 30, 2012 | 333,799.00 |
| Sep 30, 2012 | 333,799.00 |
| Jun 30, 2012 | -140,884.00 |
| Jun 30, 2012 | -140,884.00 |
| Mar 31, 2012 | -232,054.00 |
| Mar 31, 2012 | -232,054.00 |